Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.74B
-
Number of holders
-
2704
-
Total 13F shares, excl. options
-
1.29B
-
Shares change
-
+3.12M
-
Total reported value, excl. options
-
$141B
-
Value change
-
+$395M
-
Put/Call ratio
-
0.81
-
Number of buys
-
1122
-
Number of sells
-
-1148
-
Price
-
$109.79
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q4 2022
2,915 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q4 2022.
ABBOTT LABORATORIES - Common Stock (ABT) has 2,704 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.29B shares
of 1.74B outstanding shares and own 74.01% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (155M shares), BlackRock Inc. (138M shares), Capital Research Global Investors (76.8M shares), STATE STREET CORP (74.6M shares), Capital International Investors (53M shares), MORGAN STANLEY (39M shares), GEODE CAPITAL MANAGEMENT, LLC (30.6M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (24.8M shares), NORTHERN TRUST CORP (24M shares), and BANK OF AMERICA CORP /DE/ (22.4M shares).
This table shows the top 2704 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.